Circulating Soluble Endoglin Levels in Pregnant Women in Cameroon and Malawi—Associations with Placental Malaria and Fetal Growth Restriction by Silver, Karlee L. et al.
Circulating Soluble Endoglin Levels in Pregnant Women
in Cameroon and Malawi—Associations with Placental
Malaria and Fetal Growth Restriction
Karlee L. Silver
1., Andrea L. Conroy
1,2., Rose G. F. Leke
3, Robert J. I. Leke
3, Philomina Gwanmesia
3,
Malcolm E. Molyneux
4,5,6, Diane Taylor Wallace
7,8, Stephen J. Rogerson
9, Kevin C. Kain
1,2,10*
1Sandra A. Rotman Laboratories, McLaughlin-Rotman Centre for Global Health, University Health Network-Toronto General Hospital, University of Toronto, Toronto,
Ontario, Canada, 2Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada, 3Faculty of Medicine and Biomedical
Research, University of Yaounde ´, Yaounde ´, Cameroon, 4Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi, 5College of Medicine,
University of Malawi, Blantyre, Malawi, 6School of Tropical Medicine, University of Liverpool, Liverpool, United Kingdom, 7Department of Biology, Georgetown University,
Washington, D.C., United States of America, 8Department of Tropical Medicine, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, United States of
America, 9Department of Medicine, University of Melbourne, Royal Melbourne Hospital, Parkville, Victoria, Australia, 10Tropical Disease Unit, Division of Infectious
Diseases, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
Abstract
Placental infections with Plasmodium falciparum are associated with fetal growth restriction resulting in low birth weight
(LBW). The mechanisms that mediate these effects have yet to be completely described; however, they are likely to involve
inflammatory processes and dysregulation of angiogenesis. Soluble endoglin (sEng), a soluble receptor of transforming
growth factor (TGF)-b previously associated with preeclampsia in pregnant women and with severe malaria in children,
regulates the immune system and influences angiogenesis. We hypothesized that sEng may play a role in development of
LBW associated with placental malaria (PM). Plasma levels of sEng were measured in women (i) followed prospectively
throughout pregnancy in Cameroon (n=52), and (ii) in a case-control study at delivery in Malawi (n=479). The relationships
between sEng levels and gravidity, peripheral and placental parasitemia, gestational age, and adverse outcomes of PM
including maternal anemia and LBW were determined. In the longitudinal cohort from Cameroon, 28 of 52 women (54%)
experienced at least one malaria infection during pregnancy. In Malawi we enrolled two aparasitemic gravidity-matched
controls for every case with PM. sEng levels varied over the course of gestation and were significantly higher in early and
late gestation as compared to delivery (P,0.006 and P,0.0001, respectively). Circulating sEng levels were higher in
primigravidae than multigravidae from both Cameroon and Malawi, irrespective of malarial infection status (p,0.046 and
p,0.001, respectively). Peripheral parasitemia in Cameroonian women and PM in Malawian women were each associated
with elevated sEng levels following correction for gestational age and gravidity (p=0.006 and p=0.033, respectively).
Increased sEng was also associated with the delivery of LBW infants in primigravid Malawian women (p=0.017); the
association was with fetal growth restriction (p=0.003) but not pre-term delivery (p=0.286). Increased circulating maternal
sEng levels are associated with P. falciparum infection in pregnancy and with fetal growth restriction in primigravidae with
PM.
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Introduction
Low birth weight (LBW) is a well documented effect of malaria
infections in pregnancy [1], and increases the risk of death in the
first two years of life [2,3]. These effects are most highly associated
with Plasmodium falciparum infections of the placenta referred to as
placental malaria (PM) [4]. Malaria infection during pregnancy
also increases the risk of moderate or severe maternal anemia,
which is another risk factor leading to LBW [5]. Since over 85
million pregnant women are at risk of P. falciparum infection every
year [6], there is a need to better understand the mediators of poor
clinical outcomes associated with PM. Such information should
lead to better diagnosis and treatment of mothers who are at risk of
having LBW babies.
LBW resulting from maternal malaria is associated with
placental inflammation. This includes monocyte infiltration of
the placental intervillous space [7,8] and secretion of cytokines and
chemokines [9,10,11]. In addition, there is a growing body of
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LBW in the context of PM [12,13]. Inflammation and angiogen-
esis are not mutually exclusive processes, but have complementary
functions in the control of infection and injury and the limitation
of detrimental tissue neo-vascularization [14,15].
Soluble endoglin (sEng) is involved in both regulation of
immune function and angiogenesis. It exerts these effects by
binding and interfering with the activity of transforming growth
factor (TGF)-b, which is a regulatory cytokine with multiple
isoforms (e.g., TGF-b1, TGF-b3) and pleiotropic effects [16].
Specifically, sEng has been shown to reduce TGF-b1 bioavail-
ability to membrane-bound TGF-b receptors and co-receptor Eng
[17]. Eng is expressed on the membranes of endothelial cells in
adult and fetal vessels, activated monocytes and macrophages, and
placental syncytiotrophoblast [18,19,20]. The syncytiotrophoblast
is also a source of sEng [17]. By binding TGF-b, sEng may inhibit
the regulatory effects of TGF-b on the immune system. sEng also
prevents angiogenic processes such as capillary formation and
vascular permeability, and inhibits nitric oxide-mediated vasodi-
lation [17] – processes that could affect the placental vasculari-
zation required for efficient growth of the developing fetus.
Elevation of plasma sEng levels has been shown to precede the
onset of preeclampsia [17,21], a pathological pregnancy condition
that also increases the risk of preterm birth, fetal growth restriction
and LBW. Elevated concentrations of circulating sEng have been
associated with increased severity of malaria infection in children
in Gabon [22]. To date, no published studies have reported on the
relationship between PM, LBW and sEng levels. The purpose of
this study was to determine whether sEng levels are increased with
malaria in pregnancy and PM, and whether the increases are
associated with delivery of LBW infants. We measured maternal
peripheral plasma levels of sEng in two study populations; women
prospectively followed over the course of pregnancy in Cameroon,
and women studied at the time of delivery in Malawi. We report
that increased sEng levels are associated with malaria infection
and fetal growth restriction in a gravidity-dependent manner.
Methods
Ethics Statement
The prospective study in Cameroon was approved by the
Institutional Review Board, Georgetown University and the
National Ethical Committee, Ministry of Public Health, Camer-
oon. The cross-sectional study in Malawi received ethical approval
from The College of Medicine Research and Ethics Committee in
Blantyre, Malawi. Written informed consent was obtained from
each study participant. In Cameroon, if written informed consent
was unable due to illiteracy, documented verbal consent was
obtained (i.e., a third party (usually a friend of the participant)
signed that the woman had consented). This consent approach was
specifically approved by the relevant review bodies.
Participants and specimens
During 2001–2004, a cohort of pregnant women was
prospectively followed over the course of pregnancy in Yaounde ´
and Ngali II, Cameroon [23]. The transmission of P. falciparum in
Yaounde ´ is low with ,13 infectious bites/person/year [24]. Ngali
II, which is 30 km north-east of Yaounde ´, is hyperendemic for
malaria with approximately 265 infectious bites per person per
year [23]. Last menstrual period was used to calculate gestational
age at enrolment. Peripheral plasma samples were collected; thin
and thick blood smears were prepared and examined for the
presence of P. falciparum asexual parasites at monthly visits (up to
seven visits per woman) spanning all three trimesters of pregnancy.
Women who were blood-smear positive for malaria were
prescribed antimalarial treatment according to the Cameroon
Ministry of Health’s policy. Peripheral plasma samples, thin and
thick blood smears, intervillous space (IVS) blood and placental
impression smears were collected at delivery, and infant weight
was recorded. Levels of sEng were measured in samples from all
study participants who satisfied the following inclusion criteria:
primigravidae (first pregnancy) or multigravidae ($3 pregnancies)
with live singleton birth, minimum of three peripheral plasma
samples from different gestation points available for testing, and
PM status determined at delivery. A total of 244 peripheral plasma
samples from 52 women were tested for sEng. Participants infected
with Plasmodium species other than P. falciparum were not included
in this study.
To further evaluate the association of sEng levels with PM, and
with poor clinical outcomes of PM, a second study population was
also tested: Between 2001 and 2006, pregnant women who
attended the Queen Elizabeth Central Hospital (QECH) were
invited to participate in the study following delivery of a live
singleton newborn. QECH is a referral hospital in urban Blantyre
where malaria transmission is seasonal with an average of 1
infective bite per person per year [25]. Cases were defined by the
presence of P. falciparum asexual parasites present in the placental
blood, as assessed by smear. For each case, two controls that were
equal in age (62 years) and gravidity, and were negative for
malaria parasites by both peripheral and placental smear, were
enrolled. All gravidities were included in this study population
(n=479) with multigravidae being defined as more than one prior
pregnancy. Peripheral EDTA plasma samples were collected and
stored at 280uC until testing. Mononuclear cell infiltration was
assessed by microscopy, as previously described [7]: 500
intervillous blood cells under oil immersion were counted and
classified as uninfected erythrocytes, infected erythrocytes or
leukocytes (subdivided by morphology into lymphocytes, poly-
morphs or monocyte-macrophages). Those with peripheral P.
falciparum infection but no sign of placental infection (n=21) were
not included in the sEng analysis.
Poor clinical outcomes include LBW (,2500 g), anemia (,11 g
Hb/dL), growth restriction (defined as small-for-gestational-age:
,10
th centile for growth, after [26]), and preterm birth (,37
weeks gestation).
Plasma sEng measurements
Maternal peripheral plasma sEng levels were measured by
ELISA with a commercially available human sEng kit (R&D
Systems, Minneapolis, MN). All samples were tested with the
investigators blinded to group and outcome.
Statistical analyses
Continuous variables are reported as median [interquartile
range (IQR)] and analyzed by Mann-Whitney U test. Categorical
data were analyzed by Pearson’s chi-square test or Fisher’s exact
test, as appropriate. A mixed linear multivariate model was
applied to analyze the prospective study, with gestational age,
gravidity, presence of peripheral parasites, and placental malaria
infection as fixed variables, and study participant as a random
variable. End of gestation (delivery), primigravidae, absence of
peripheral parasitemia and absence of placental malaria infection
were set as reference points for the fixed variables, respectively.
Two-factor effects of log-transformed data (normalized) were
analyzed by 2-way ANOVA; between-group effects were analyzed
by Bonferonni post-tests. Correlations between continuous vari-
ables were analyzed by Spearman’s correlation or partial
correlation on log-transformed data to control for the effect of
Soluble Endoglin in Placental Malaria
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were performed using Prism 4.03 (GraphPad Software, La Jolla,
CA) or SPSS (Chicago, IL).
Results
Characteristics of study populations
Characteristics of the prospective study population are listed in
Table 1, and illustrated in Figure 1. Of 52 women who satisfied the
criteria for the Cameroon study, 22 were primigravid and 30 were
multigravid. As expected, multigravidae were older and delivered
larger infants than primigravidae (Table 1). No difference was
observed between gravidities in the gestational age of participants at
enrolment, the number of antenatal visits, or the gestational age at
delivery. Malaria infections were detected at least once (median
[IQR]=2 [1–3] times) in gestation (median [IQR]=6 [5.5–7]
prenatal visits) or at delivery in 28 women, 15 primigravidae and 13
multigravidae. 40% of the incidents of malaria infections were
detected after30weeksofgestation,whenthefetalgrowthvelocityis
at its highest [27]. The other 24 participants were blood-smear
negative at all prenatal visits (median [IQR]=6 [6–7] visits) and at
delivery. Together, the primigravid women delivered infants with
lower birth weight than multigravid women. Only 3 women (2
primigravid and 1 multigravid)delivered infants weighing ,2500 g,
this incidence of LBW being likely due to the effective provision of
monthly prenatal care including malaria prophylaxis and iron
supplementation [23].
Characteristics of the cross-sectional study population are listed
in Table 2, and illustrated in Figure 1. Since we enrolled two
malaria-negative participants enrolled for every malaria-positive
participant, one third of the women in each gravidity group were
malaria positive. Parasites were detected in both the peripheral
and placental compartments in 116 women (77 primigravidae and
39 multigravidae) and only placental parasites were detected in 24
women (15 primigravidae and 9 multigravidae). Malaria-infected
primigravid women had on average higher levels of placental
parasitemia (Table 2) and mononuclear cell infiltration (primi-
gravid, 10.0 [0–22.5] vs. multigravid, 5.0 [0–18.8] mononuclear
cells per 500 cells; p=0.016) than infected multigravid women.
Multigravidae were older and delivered infants with higher birth
weight than primigravidae.
Soluble endoglin levels change with gestation and
gravidity
Since sEng is secreted by the placental syncytiotrophoblast and
has anti-angiogenic effects on endothelial cells that might be
important for physiologic placental vascular remodelling during
gestation [17], we first examined if its expression is altered with
the stage of gestation in the prospective study population in
Cameroon. Mean maternal peripheral sEng levels varied with
gestation age (p,0.0001 by univariate analysis). In a multivariate
analysis taking into account gestational age, gravidity and presence
of peripheral malaria infection, mean sEng concentration was
significantly higher in early (,14 weeks) and late (.33 weeks)
gestation than at delivery (p,0.004 and p,0.0001, respectively;
Fig. 2A).
Soluble endoglin levels change with gravidity
Gravidity is an important factor in the susceptibility to PM, with
primigravidae being more susceptible to both infection and to
sequelae resulting from infection [4]. The same multivariate
analysis on the Cameroonian study population results, accounting
for gestational age and the presence of peripheral or placental
parasites, showed that mean maternal sEng levels were higher in
primigravid than in multigravid women (p,0.046; Fig. 2B). This
association was also observed at delivery in the Malawian
population, with primigravidae having higher median sEng levels
(50.2 [39.5–64.3] ng/mL) than multigravidae (43.2 [31.9–52.8]
ng/mL; p,0.001).
Malaria in pregnancy increases soluble endoglin levels
In the Cameroonian study population, the presence of
peripheral parasitemia during pregnancy was associated with an
increase in maternal sEng levels when gestational age and
gravidity were taken into account (p=0.006; Fig. 2C). Likewise,
maternal sEng was increased with PM infection in the Malawian
population (p,0.05), after controlling for gestational age and
gravidity (Fig. 3).
Since the Malawian cross-sectional study population had a larger
number of women, it was possible to further explore the association of
increased sEng and PM at delivery. A weak but significant correlation
was observed between peripheral sEng levels and peripheral or
placentalparasitemia(peripheral: Spearman’s rho=0.198, p=0.001;
placental: rho=0.179, p=0.002). Among women with placental
malaria infection, sEng was positively correlated with placental
monocyte infiltration (rho=0.127, p=0.007); however, the relation-
ship was strongest in primigravidae with PM (rho=0.303, p=0.004).
Soluble endoglin levels are highest among women with
poor clinical outcomes of malaria in pregnancy
In the Malawian study population, 51 (17.5%) of the
primigravid women and 9 (5.5%) of the multigravid women
delivered LBW infants. Among primigravidae only, the median
Table 1. Characteristics of prospective study population (Cameroon).
Primigravid (n=22) Multigravid (n=30) P value
Age, years 20 (18–24) 28 (24–32) ,0.0001
Number (%) who were blood-smear positive $1 times during pregnancy 15 (68%) 13 (43%) 0.096
a
Number (%) with PM at delivery 7 (32%) 5 (17%) 0.320
a
Gestational age at enrolment, weeks 14 (13–15.5) 13 (12–15.5) 0.201
Number of antenatal visits 6 (6–7) 6 (6–7) 0.289
Gestational age at delivery, weeks 39.5 (39–41) 40 (39–41) 0.831
Birth weight,g 2815 (2600–3200) 3400 (2975–3710) 0.0001
Data shown as median (interquartile range), except where noted.
aFisher’s exact test.
doi:10.1371/journal.pone.0024985.t001
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mothers of normal birth weight infants (Mann-Whitney, p=0.017;
Fig. 4A). These higher concentrations of sEng in primigravidae
were associated with fetal growth restriction (small for gestational
age (n=92) vs normal for gestational age (n=197), p=0.003) but
not with preterm birth (preterm (n=54) vs term birth (n=235),
p=0.286).
Stratification of primigravid participants by malaria infection
and birth weight illustrates that both PM and LBW outcomes were
associated with increased peripheral sEng levels at delivery (2-way
ANOVA (log10[sEng]): PM, p=0.008; LBW, p=0.006; Fig. 4B).
Peripheral sEng levels in primigravidae with malaria were
negatively correlated with birth weight when correcting for
gestational age at delivery (rho=20.237, p,0.001). This
correlation was not observed in the multigravid group
(rho=0.031, p=0.693).
We also examined the change in sEng with anemia, another
poor clinical outcome associated with both PM and LBW [5].
Figure 1. Overview of study populations from Cameroon and Malawi: timing of malaria infections during pregnancy in Cameroon
and summary of adverse birth outcomes from Malawi. Women who participated in the longitudinal study in Cameroon were followed
throughout gestation, at up to 7 antenatal visits and at delivery. Peripheral P. falciparum malaria infection was assessed by microscopy of peripheral
blood smear at each visit; MIP+, blood-smear positive. Women who participated in the cross-sectional study in Malawi were enrolled at delivery.
Placental malaria (PM) was determined by microscopy of placental blood smear. Adverse birth outcomes were defined as normal birth weight (NBW,
$2500 g) or low birth weight (LBW, ,2500 g) with or without growth restriction (small for gestational age (SGA), less than 10
th centile according to
[26]) or preterm delivery (PTD, ,37 weeks of gestation).
doi:10.1371/journal.pone.0024985.g001
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(p=0.019; Fig. 4C). However, in a multivariable logistic regression
model with age and parasitemia as covariates, sEng was not an
independent predictor of anemia (p=0.102).
Discussion
Circulating sEng levels correlate with severity of disease in both
preeclamptic women and P. falciparum-infected children [17,22].
By measuring sEng in maternal plasma at various stages of
pregnancy in a longitudinal study in Cameroon and in a large
case-control cross-sectional study from Malawi, we were able to
show that circulating sEng levels were associated with poor
outcomes of malaria infection in pregnancy. sEng was increased in
pregnant women with peripheral malaria parasitemia during
pregnancy, and peripheral sEng levels at delivery were increased
in the presence of PM. Maternal sEng levels at delivery also
correlated with fetal growth restriction.
These two geographically distinct populations showed similar
increases in sEng levels in primigravidae and malaria infected
women, despite differences in malaria endemicity and likely
diversity in host and parasite genetics. These results suggest that
these findings may be generalizable to other populations.
Table 2. Characteristics of cross-sectional study population (Malawi).
Primigravid (n=292) Multigravid (n=166) P value
Age, years 18.0 (17.0–20.0) 25.0 (22.0–28.0) ,0.001
Hemoglobin concentration, g/dL 12.0 (10.5–13.3) 11.8 (10.6–12.9) 0.388
Number (%) with PM at delivery
a 92 (31.5) 48 (28.9) 0.563
Placental parasites in infected mothers,p e rmL 70.0 (21.0–446.0) 40.0 (9.3–111.5) 0.013
Gestational age at delivery, weeks 38 (38–40) 40 (38–40) ,0.001
Birth weight, g 2800 (2563–3138) 3150 (2900–3450) ,0.001
Data shown as median (interquartile range), except where noted.
aProduct of study design with two malaria-negative control enrolled for each malaria-positive case enrolled.
doi:10.1371/journal.pone.0024985.t002
Figure 2. Maternal sEng levels are affected by gravidity, gestational age and malaria infection. sEng levels measured in peripheral
plasma samples from study participants were peripheral blood-smear negative at all study visits, shown as (A) all gravidities together, and (B) split
into primigravidae (PG) and multigravidae (MG). (C) Levels of sEng from all study participants split into those with P. falciparum infection detected at
one or more antenatal visit or at delivery (Malaria) or blood-smear negative at all study visits (Uninfected). Multi-order polynomial non-linear
regression curves with the best fits to the data are depicted to illustrate the effect trends in peripheral sEng levels throughout gestation.
doi:10.1371/journal.pone.0024985.g002
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plasma samples is unknown. Cell types that have been implicated in
PM, including endothelial cells, activated monocytes and macro-
phages, have been shown to express Eng [18,19,20]. Syncytiotro-
phoblastisa sourceofsEng [17];however sEng has been detected in
non-pregnant individuals (e.g., children with severe malaria [22]),
and thus is likely also cleaved from the surface of other Eng-
expressing cells by matrix metalloproteinases [28].
The changes we observed in the levels of sEng with malaria
were small, though consistent. This small range coupled with
natural variation between individuals pre-empts the use of sEng as
a stand-alone biomarker for either PM or for individuals at risk of
poor outcomes. However, it may prove to be more informative
when coupled with other biomarkers of PM, as is the case for
preeclampsia, where the utility of sEng as a prognostic biomarker
is strengthened when combined with measurements of soluble Flt-
1 and placental growth factor [21,29].
Our findings, coupled with an understanding of the biological
effects of sEng, lead us to suggest that sEng may play a role in
mediating the pathogenesis of fetal growth restriction associated
with PM. sEng binds to TGF-b, and thereby limits TGF-b
bioavailability [17]. The increase of sEng we observed in maternal
plasma of primigravid women with PM is consistent with reports
that PM is associated with a decrease in maternal and placental
TGF-b levels [10,30,31]. The levels of TGF-b1 have also been
shown to be inversely correlated with malaria disease severity
[32,33], and to be important in dictating severity of pathology in
murine models of malaria [34,35,36]. TGF-b has multiple
biological functions, including immune regulation, vascular
development, and hematopoeisis [37,38,39]. sEng may be
mediating LBW in the context of PM by interfering with any of
these effects, and, owing to the pleiotropic nature of its ligand, it is
likely that any effect sEng may have on fetal growth restriction
occurs through several mechanisms.
Monocytic infiltration of the placenta is a strong correlate of
LBW in PM [7,8]. TGF-b can have both pro- and anti-
Figure 3. Maternal sEng at delivery is increased with placental
malaria in primigravidae and not multigravidae. sEng was
measured in peripheral plasma samples of Malawian women at
delivery. Placental malaria (PM+) was defined as positive by placental
blood smear microscopy. Bars represent medians. 2-way ANOVA on
log-transformed data: gravidity, p,0.0001. *, p,0.05; **, p,0.01;
***, p,0.001 by Bonferonni post-test.
doi:10.1371/journal.pone.0024985.g003
Figure 4. Elevated maternal sEng at delivery is associated with poor clinical outcomes in primigravidae. sEng was measured in
peripheral plasma samples of Malawian women at delivery. Results displayed by (A) gravidity and birth weight; (B) birth weight and placental malaria
(PM) status for primigravidae only; (C) anemia and PM status for primigravidae only. PM was defined as P. falciparum positivity in placental blood
smear by microscopy. Anemia was defined as ,11 g Hb/dL. NBW, normal birth weight; LBW, low birth weight. Bars represent medians. *, p,0.05;
**, p,0.01; ***, p,0.001 by Bonferonni post-test of 2-way ANOVA on log-transformed data.
doi:10.1371/journal.pone.0024985.g004
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macrophage lineage depending on the activation state of the cells
[16]. TGF-b is a potent chemoattractant for monocytes and has
been shown to potentiate inflammation via IL-1 and IL-6 secretion
[40,41,42]. TGF-b also induces monocyte secretion of matrix
metalloproteinases [41]. In this way sEng may be cleaved from
syncytiotrophoblast to control TGF-b–dependent monocyte
infiltration and inflammation. A model whereby sEng is cleaved
in response to monocyte infiltration is supported by the correlation
between mononuclear cell infiltrates and sEng levels in Malawian
primigravidae with PM.
Once monocytes differentiate into macrophages, TGF-b
induces an anti-inflammatory effect by inhibiting secretion of
TNF, chemokines, and nitric oxide [16]. This effect was observed
in mice in whom recombinant TGF-b treatment induced IL-10,
decreased TNF, and prolonged survival time to infection with the
rodent parasite Plasmodium berghei [35]. Conversely, increases in
sEng that result in reduction of bioactive TGF-b in PM may
interfere with this anti-inflammatory role, and favour the
establishment of a pro-inflammatory environment. A ratio of
TNF:IL-10 that favours TNF has been associated with severe
malaria in children [33], and with LBW outcomes of PM [11].
Increased sEng may also mediate fetal growth restriction by
acting directly on the placental vasculature. This contention is
supported by our observations that circulating sEng is expressed at
higher amounts at times in gestation that correspond to uterine
invasion by trophoblast (early gestation) [43] and active vascular
remodelling to support optimal fetal growth (last trimester;
Fig. 2A). TGF-b is known to both inhibit trophoblast proliferation,
migration and uterine invasion [44,45], and to promote
endothelial cell proliferation and migration [46], depending on
the signalling pathway and cell type targeted. sEng has been
shown to reduce endothelial cell sprouting and capillary
vasodilation by blocking TGF-b activity [17]. Increased levels of
sEng have been correlated with increased impedance to uterine
and umbilical arterial blood flow [47]. The early increase in sEng
level, which does not appear to change with gravidity (Fig. 2A), is
likely required for normal placentation while malaria-induced
increases in sEng in later gestation (Fig. 2C) may restrict TGF-b–
mediated placental vessel growth and lead to functional placental
insufficiency and impaired fetal growth.
A third way that sEng may mediate fetal growth restriction is by
dysregulating erythropoeisis. We observed an increase in sEng
levels with maternal anemia in primigravidae, and previous
reports have associated anemia with LBW [11,48]. Erythrocyte
proliferation and differentiation requires TGF-b signalling
through membrane-bound Eng [39,49], thus decreased bioavail-
able TGF-b as a result of increased sEng may reduce the number
of erythrocytes in circulation and, therefore, the amount of oxygen
that is delivered to the fetus. Given that sEng was not an
independent predictor of anemia, it is also possible that high
parasitemia caused proportional but unrelated variations in both
sEng levels and hemoglobin levels in primigravidae.
The mechanism(s) by which sEng may mediate growth
restriction in PM will be more thoroughly informed by a
prospective study that involves serial blood sampling together
with ultrasound measurements of fetal growth to assess how
changes in sEng at different points in gestation related to fetal
development. It would also be informative to measure TGF-b
alongside sEng; however, circulating TGF-b must be measured in
platelet poor plasma, which was not collected from the current
study populations.
HIV infection status was unknown in our study participants, but
the prevalence of HIV infection in pregnant women was 7% and
30% in Cameroon and Malawi, respectively, during the periods of
recruitment [50,51]. While HIV, and other co-infections, may
affect sEng levels, it is unlikely to be a significant confounder of the
results presented in this study, as the two populations with different
levels of HIV prevalence showed the same results.
To our knowledge, this is also the first study to describe elevated
sEng levels in first pregnancies. Primigravidae are known to be
more susceptible to malaria infection and sequelae associated with
malaria [52]. The increased susceptibility in primigravidae is
thought to be primarily due to a lack of antibodies specific for
placental chondroitin sulphate A (CSA)-binding parasites that can
prevent sequestration and promote opsonic clearance of infected
erythrocytes in the placenta [11,53,54]. Primigravidae are also at
higher risk of developing preeclampsia. Immune maladaption to
the semi-allogenic fetus has been suggested as an explanation for
this susceptibility [55]. Higher baseline systemic levels of sFlt-1, an
anti-inflammatory and anti-angiogenic protein, have also been
noted in first time pregnancies [56]. Increased constitutive sFlt-1
and sEng expression may keep heightened basal immune system
activation in check, but also predispose primigravidae to poor
clinical outcomes such as hypertension and fetal growth restriction.
The absence of increased sEng in malaria-infected multigravidae
(Fig. 2 and 4A), i.e., those less susceptible to PM sequelae, is also
consistent with this hypothesis.
In conclusion, we found that maternal circulating sEng is
increased with P. falciparum infection in pregnancy and with fetal
growth restriction in primigravidae with PM. These changes are
not sufficient for sEng on its own to be a useful biomarker of these
conditions, but its potential in combination with other biomarkers
deserves further study. Our findings are compatible with the
hypothesis that sEng may play a role in the pathogenesis of PM-
related fetal growth restriction.
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